Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II

Pulmonary fibrosis

Pulmonary Fibrosis Lung Sounds Study A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects Safety of Nintedanib in Real World in China A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis Oxygen Nanobubble Drink Impact on Exercise in Pulmonary Fibrosis A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study Safety and Effectiveness of EV-Pure + WJ-Pure Treatment on Pulmonary Fibrosis Secondary to Covid-19 Pulmonary Fibrosis Foundation Community Registry FAPI PET for Lung Fibrosis Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis A Study to Evaluate the Safety and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid Fibrosis Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients. Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions Pulmonary Fibrosis During Severe COVID-19 Pneumonia Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital Post Acute Sequelae of COVID-19 Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs Dyspnea and Idiopathic Pulmonary Fibrosis COVID-19 Pathophysiology of Long Term Implications The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 A Non-pharmacological Cough Control Therapy Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID Advancing Prevention of Pulmonary Fibrosis Vaccination of Ex-acute COVID Patied-19 Patients With Fibrosing Lung Syndrome at Discharge Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients BIO 300 Oral Suspension in Discharged COVID-19 Patients Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION European Management Platform for Childhood Interstitial Lung Diseases – chILD-EU Register and Biobank Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study Using Health-related Quality of Life (HRQL) in Routine Clinical Care Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease Accuracy of Spircare Device as Compared to the Conventional Plethysmograph Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation Segmental Bronchoalveolar Lavage Comparative Study of 3 Portable Oxygen Concentrators During a 6-minute Walk Test in Patients With Chronic Lung Disease Spanish Version of the KBILD Questionnaire Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases Computerized Lung Sound Analysis Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF Assessment of Pulmonary Specialty Physicians’ Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases Linkage Study in Familial Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis: a Case-control Study Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) Diagnostic Value of KL-6 in ILD Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174) Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System Biology An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF) Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed iNO in Subjects With Pulmonary Fibrosis Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study RENOVATE Fibrosis: Pilot Study Comparing HFNC Versus NIPPV in Acute Respiratory Failure in Patients With Pulmonary Fibrosis Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF) Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) Lung Disease Associated With Rheumatoid Arthritis Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF) Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF) Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients Effects of Pulmonary Rehabilitation on Functional and Health Status Measures in Pulmonary Fibrosis Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis Explanted Lung Tissues With Pulmonary Fibrosis Pulmonary Fibrosis and Telomerase Mutation Study Dyspnea in Patients With Pulmonary Fibrosis Supplemental Oxygen in Pulmonary Fibrosis